MALDI imaging mass spectrometry: Bridging biology and chemistry in drug development

Bioanalysis

Volumn 3, Issue 21, 2011, Pages 2427-2441

  Castellino, Stephen ^a   Groseclose, M Reid ^a   Wagner, David ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAPATINIB;

ANALYTIC METHOD; DRUG TISSUE LEVEL; INTERMETHOD COMPARISON; LIMIT OF DETECTION; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR IMAGING; NONHUMAN; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TISSUE PREPARATION;

ANIMALS; DRUG DISCOVERY; DRUG INTERACTIONS; HUMANS; PHARMACEUTICAL PREPARATIONS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TISSUE DISTRIBUTION;

EID: 81055144381     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.232     Document Type: Review

References (66)

1. Marko-Varga G, Fehniger TE, Rezeli M et al.Drug localization in different lung cancer phenotypes by MALDI mass spectrometry imaging.J.Proteomics 74(7), 982-992 (2011).
2. Lanao JM, Fraile MA.Drug tissue distribution: study methods and therapeutic implications.Curr.Pharm.Des.11(29), 3829-3845 (2005). (Pubitemid 41632256)
3. Langer O, Muller M.Methods to assess tissue-specific distribution and metabolism of drugs.Curr.Drug Metab.5(6), 463-481 (2004). (Pubitemid 39534493)
4. Monro AM.Interspecies comparisons in toxicology: the utility and futility of plasma concentrations of the test substance.Regul.Toxicol.Pharmacol.12(2), 137-160 (1990). (Pubitemid 20337296)
5. Mouton JW, Theuretzbacher U, Craig WA et al.Tissue concentrations: do we ever learn? J.Antimicrob.Chemother.61(2), 235-237 (2008).
6. Ryan DM, Cars O, Hoffstedt B.The use of antibiotic serum levels to predict concentrations in tissues.Scand.J.Infect.Dis.18(5), 381-388 (1986). (Pubitemid 16017363)
7. Pellegatti M, Pagliarusco S.Drug and metabolite concentrations in tissues in relationship to tissue adverse findings: a review.Expert Opin.Drug Metab.Toxicol.7(2), 137-146 (2011).
8. Solon EG, Schweitzer A, Stoeckli M et al.Autoradiography, MALDI-MS and SIMS-MS imaging in pharmaceutical discovery and development.AAPS J.12(1), 11-26 (2010).
9. Solon EG.Autoradiography: high-resolution molecular imaging in pharmaceutical discovery and development.Expert Opin.Drug Discov.2(4), 503-514 (2007). (Pubitemid 47073075)
10. Stumpf WE.Drug localization and targeting with receptor microscopic autoradiography.J.Pharmacol.Toxicol.Methods 51(1), 25-40 (2005). (Pubitemid 41556701)
11. Sugiura Y, Setou M.Imaging mass spectrometry for visualization of drug and endogenous metabolite distribution: toward in situ pharmacometabolomes.J. Neuro.Pharmacol.5(1), 31-43 (2010).
12. Khatib-Shahidi S, Andersson M, Herman JL et al.Direct molecular analysis of whole-body animal tissue sections by imaging MALDI mass spectrometry.Anal. Chem.78(18), 6448-6456 (2006). (Pubitemid 44418954)
13. Stoeckli M, Staab D, Schweitzer A.Compound and metabolite distribution measured by MALDI mass spectrometric imaging in whole-body tissue sections.Int.J.Mass Spec.260(2-3), 195-202 (2006).
14. Heeren RM, Smith DF, Stauber J et al.Imaging mass spectrometry: hype or hope? J.Am.Soc.Mass Spectrom.20(6), 1006-1014 (2009).
15. Seeley EH, Caprioli RM.MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives.Trends Biotechnol.29(3), 136-143 (2011).
16. Schwamborn K, Caprioli RM.MALDI imaging mass spectrometry - painting molecular pictures.Mol.Oncol.4(6), 529-538 (2010).
17. Schwamborn K, Caprioli RM.Molecular imaging by mass spectrometry - looking beyond classical histology.Nat.Rev.Cancer 10(9), 639-646 (2010).
18. Svatos A.Mass spectrometric imaging of small molecules.Trends Biotechnol.28(8), 425-434 (2010).
19. Goodwin RJ, Pitt AR.Mass spectrometry imaging of pharmacological compounds in tissue sections.Bioanalysis 2(2), 279-293 (2010).
20. Pol J, Strohalm M, Havlicek V et al.Molecular mass spectrometry imaging in biomedical and life science research.Histochem.Cell Biol.134(5), 423-443 (2010).
21. Amstalden van Hove ER, Smith DF, Heeren RM.A concise review of mass spectrometry imaging.J.Chromatogr.A 1217(25), 3946-3954 (2010).
22. Vickerman JC.Molecular imaging and depth profiling by mass spectrometry - SIMS, MALDI or DESI? Analyst 136(11), 2199-2217 (2011).
23. Goodwin RJ, Pitt AR.Mass spectrometry imaging of pharmacological compounds in tissue sections.Bioanalysis 2(2), 279-293 (2010).
24. Greer T, Sturm R, Li L.Mass spectrometry imaging for drugs and metabolites.J.Proteomics doi:10.1016/j.jprot.2011.03.032 (2011) (Epub ahead of print).
25. Rubakhin SS, Sweedler JV.A mass spectrometry primer for mass spectrometry imaging.Methods Mol.Biol.656, 21-49 (2010).
26. Knochenmuss R.Ion formation mechanisms in UV-MALDI.Analyst 131(9), 966-986 (2006). (Pubitemid 44313637)
27. Chaurand P, Cornett DS, Angel PM et al.From whole-body sections down to cellular level, multiscale imaging of phospholipids by MALDI mass spectrometry.Mol.Cell Proteomics 10(2), O110.004259 (2011).
28. Lemaire R, Desmons A, Tabet JC et al.Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections.J.Proteome.Res.6(4), 1295-1305 (2007). (Pubitemid 46724026)
29. Groseclose MR, Massion PP, Chaurand P et al.High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry.Proteomics 8(18), 3715-3724 (2008).
30. Drexler DM, Garrett TJ, Cantone JL et al.Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues.J.Pharmacol.Toxicol.Methods 55(3), 279-288 (2007). (Pubitemid 46436524)
31. Strohalm M, Strohalm J, Kaftan F et al.Poly[N-2hydroxypropyl) methacrylamide]- based tissue-embedding medium compatible with MALDI mass spectrometry imaging experiments.Anal.Chem.83(13), 5458-5462 (2011).
32. Dreisewerd K.The desorption process in MALDI.Chem.Rev.103(2), 395-426 (2003).
33. Horneffer V, Forsmann A, Strupat K et al.Localization of analyte molecules in MALDI preparations by confocal laser scanning microscopy.Anal.Chem. 73(5), 1016-1022 (2001). (Pubitemid 32204918)
34. Knochenmuss R, Zenobi R.MALDI ionization: the role of in-plume processes.Chem.Rev.103(2), 441-452 (2003).
35. Knochenmuss R.Photoionization pathways and free electrons in UV-MALDI.Anal.Chem.76(11), 3179-3184 (2004). (Pubitemid 38715712)
36. Knochenmuss R, Zhigilei LV.Molecular dynamics simulations of MALDI: laser fluence and pulse width dependence of plume characteristics and consequences for matrix and analyte ionization.J.Mass Spectrom.45(4), 333-346 (2010).
37. Hawkridge AM, Muddiman DC.Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality.Annu.Rev.Anal.Chem.(Palo.Alto. Calif.) 2, 265-277 (2009).
38. Jaskolla T, Karas M.Compelling evidence for lucky survivor and gas phase protonation: the unified MALDI analyte protonation mechanism.J.Am.Soc.for Mass Spectrom.22(6), 976-988 (2011).
39. Aerni HR, Cornett DS, Caprioli RM.Automated acoustic matrix deposition for MALDI sample preparation.Anal.Chem.78(3), 827-834 (2006). (Pubitemid 43228590)
40. Murphy RC, Hankin JA, Barkley RM et al.MALDI imaging of lipids after matrix sublimation/deposition.Biochim.Biophys.Acta DOI:10.1016/j.bbalip.2011.06. 019 (2011) (Epub ahead of print).
41. Hankin JA, Barkley RM, Murphy RC.Sublimation as a method of matrix application for mass spectrometric imaging.J.Am.Soc.Mass Spectrom.18(9), 1646-1652 (2007). (Pubitemid 47302327)
42. Chaurand P, Schwartz SA, Capriolo RM.Profiling and imaging proteins in tissue sections by MS.Anal.Chem.76(5), 87A-93A (2004).
43. Deininger SO, Cornett DS, Paape R et al.Normalization in MALDI-TOF imaging datasets of proteins: practical considerations.Anal.Bioanal.Chem.401(1), 167-181 (2011).
44. Bonnel D, Legouffe R, Willand et al.MALDI imaging techniques dedicated to drug-distribution studies.Bioanalysis 3(12), 1399-1406 (2011).
45. Borgaonkar SP, Hocker H, Shin H et al.Comparison of normalization methods for the identification of biomarkers using MALDI-TOF and SELDI-TOF mass spectra.OMICS 14(1), 115-126 (2010).
46. Deininger SO, Cornett DS, Paape R et al.Normalization in MALDI-TOF imaging datasets of proteins: practical considerations.Anal.Bioanal.Chem.401(1), 167-181 (2011).
47. Meuleman W, Engwegen JY, Gast MC, et al.Comparison of normalisation methods for surface-enhanced laser desorption and ionisation (SELDI) time-of-flight (TOF) mass spectrometry data.BMC Bioinformatics 9, 88 (2008).
48. Reyzer ML, Hsieh Y, Ng K et al.Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry.J.Mass Spectrom.38(10), 1081-1092 (2003). (Pubitemid 37407703)
49. Koeniger SL, Talaty N, Luo Y et al.A quantitation method for mass spectrometry imaging.Rapid Commun.Mass Spectrom.25(4), 503-510 (2011).
50. Yamada Y, Hidefumi K, Shion H et al.Distribution of chloroquine in ocular tissue of pigmented rat using matrix-assisted laser desorption/ionization imaging quadrupole time-of-flight tandem mass spectrometry.Rapid Commun.Mass Spectrom.25(11), 1600-1608 (2011).
51. Hu Q, Noll RJ, Li H et al.The Orbitrap: a new mass spectrometer.J.Mass Spectrom.40(4), 430-443 (2005). (Pubitemid 40637866)
52. Perry RH, Cooks RG, Noll RJ.Orbitrap mass spectrometry: instrumentation, ion motion and applications.Mass Spectrom.Rev.27(6), 661-699 (2008).
53. Marshall AG, Hendrickson CL, Jackson GS.Fourier transform ion cyclotron resonance mass spectrometry: a primer.Mass Spectrom.Rev.17(1), 1-35 (1998). (Pubitemid 128629493)
54. Bristow AW.Accurate mass measurement for the determination of elemental formula - a tutorial.Mass Spectrom.Rev.25(1), 99-111 (2006).
55. Zhang H, Zhu M, Ray KL et al.Mass defect profiles of biological matrices and the general applicability of mass defect filtering for metabolite detection.Rapid Commun.Mass Spectrom.22(13), 2082-2088 (2008). (Pubitemid 351956694)
56. Zhang H, Zhang D, Ray K et al.Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry.J.Mass Spectrom.44(7), 999-1016 (2009).
57. Zhang D, Cheng PT, Zhang H.Mass defect filtering on high resolution LC-MS data as a methodology for detecting metabolites with unpredictable structures: identification of oxazole-ring opened metabolites of muraglitazar.Drug Metab.Lett.1(4), 287-292 (2007).
58. Hopfgartner G, Varesio E, Stoeckli M.Matrix-assisted laser desorption/ionization mass spectrometric imaging of complete rat sections using a triple quadrupole linear ion trap.Rapid Commun.Mass Spectrom.23(6), 733-736 (2009).
59. Prideaux B, Dartois V, Staab D et al.High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions.Anal.Chem.83(6), 2112-2118 (2011).
60. Rompp A, Guenther S, Takats Z et al.Mass spectrometry imaging with high resolution in mass and space (HR(2) MSI) for reliable investigation of drug compound distributions on the cellular level.Anal.Bioanal.Chem.401(1), 65-73 (2011).
61. McLean JA, Fenn LS, Enders JR.Structurally selective imaging mass spectrometry by imaging ion mobility-mass spectrometry.Methods Mol.Biol.656, 363-383 (2010).
62. McLean JA, Ridenour WB, Caprioli RM.Profiling and imaging of tissues by imaging ion mobility-mass spectrometry.J.Mass Spectrom.42(8), 1099-1105 (2007). (Pubitemid 47255462)
63. Kanu AB, Dwivedi P, Tam M et al.Ion mobility-mass spectrometry.J.Mass Spectrom.43(1), 1-22 (2008). (Pubitemid 351251969)
64. Woods AS, Jackson SN.The application and potential of ion mobility mass spectrometry in imaging MS with a focus on lipids.Methods Mol.Biol.656, 99-111 (2010).
65. Chaurand P, Schriver KE, Caprioli RM.Instrument design and characterization for high resolution MALDI-MS imaging of tissue sections.J.Mass Spectrom.42(4), 476-489 (2007). (Pubitemid 46649084)
66. Jurchen JC, Rubakhin SS, Sweedler JV.MALDI-MS imaging of features smaller than the size of the laser beam.J.Am.Soc.Mass Spectrom.16(10), 1654-1659 (2005). (Pubitemid 41345157)